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S U M M A R Y
Cryptococcus neoformans is a ubiquitous organism that often causes opportunistic infections in immune-
compromised patients. The pulmonary and central nervous systems are most commonly affected.
Osseous involvement is infrequent and is usually associated with disseminated systemic infection.
Isolated cryptococcal osteomyelitis is exceedingly rare. We report the case of a 56-year-old
immunocompetent man who presented with isolated cryptococcal osteomyelitis of the humerus.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Cryptococcosis remains an important opportunistic infection,
especially in the era of HIV infection in South Africa.1 Cryptococ-
cosis most commonly affects the lung and central nervous system
(CNS).1 Other sites of infection remain unusual.1 An unusual
presentation of cryptococcal osteomyelitis in an HIV-seronegative
man with no other features of immunosuppression is presented.
2. Case report
We report the case of a 56-year-old male diagnosed with
isolated cryptococcal osteomyelitis of the humerus. He was
referred to a tertiary care orthopedic tumor unit 2 months after
sustaining a pathological fracture through a lytic lesion of his left
humerus. At the time he was employed as a painter on an
agricultural farm. The injury was sustained at work when a piece of
metal roof sheeting fell directly onto his left arm. He was otherwise
well with no previous medical illnesses.
Local staging included radiographs and a magnetic resonance
imaging (MRI) scan before histological examination of the lesion.
Radiographs revealed an oblique fracture through a lytic lesion in
diaphyseal bone at the junction of the middle and distal third of the* Corresponding author.
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(H. Dawood).
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http://dx.doi.org/10.1016/j.ijid.2013.04.013left humerus. The lesion appeared purely lytic, geographic, poorly
marginated, and had no discernible matrix. Minimal periosteal
reaction was present, and the fracture showed signs of early union.
The MRI scan demonstrated an ill-deﬁned, irregular medullary
lesion, suggestive of an infectious etiology (Figure 1).
Systemic staging included host staging in terms of immune
competency and screening for possible primary malignancies and
concomitant lesions. An ELISA test for HIV was negative, whilst his
serum cryptococcal latex agglutination test (CLAT) was positive.
Cerebrospinal ﬂuid examination was normal with both the CLAT
and India ink stain negative. He had no clinical features of systemic
lupus erythematosus and was found to have a normal glucose
level. Serum calcium, prostate-speciﬁc antigen, and myeloma
screening were normal. Bone scintigraphy showed increased
activity in the mid-shaft of the left humerus, with no other bony
lesions noted. A chest radiograph and computer tomography (CT)
of the chest, abdomen, and pelvis were normal, with no evidence of
malignancy or associated lesions.
Whilst undergoing local and systemic staging, a sinus devel-
oped on the antero-lateral aspect of his upper arm that drained a
non-offensive purulent discharge. Open, incisional biopsy in
theatre revealed necrotic tissue and minimal pus. Specimens
were taken and sent for histology, bacterial, fungal, and
tuberculosis microscopy, culture, and sensitivity. The fracture
was clinically united, and no further immobilization was required.
Histological examination showed features of chronic osteomy-
elitis with no evidence of malignancy. Microbiological investiga-
tion conﬁrmed the diagnosis by culture of Cryptococcus neoformansses. Published by Elsevier Ltd. All rights reserved.
Figure 1. MRI of the left humerus showing an ill-deﬁned, irregular medullary lesion.
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not genotyped and hence we were unable to distinguish between
Cryptococcus gattii and C. neoformans.
The patient was commenced on amphotericin B at 1 mg/kg/day
for his cryptococcal infection. His management was complicated
by the development of renal impairment by day 8, despite
rehydration with intravenous ﬂuids. The amphotericin B was
withheld after 9 days of intravenous therapy and ﬂuconazole
400 mg daily was commenced. His renal function returned to
normal within 5 days. He was thereafter recommenced on
amphotericin B, but due to a recurrence of renal impairment this
was stopped again. A total of 12 days of amphotericin B was
administered. Fluconazole 400 mg daily was continued for 10
weeks before the dose was lowered to 200 mg daily. The
ﬂuconazole treatment was continued for 6 months and his renal
function remains normal.
Repeat radiographs of the fracture site have shown that the
fracture has united in an acceptable position and will not require
any further surgical intervention.
3. Discussion
Cryptococcus is a systemic mycosis caused by an encapsulated
‘yeast’ fungus and exists as two species: C. neoformans and C.
gattii.1 C. neoformans is prevalent worldwide.1 It is found in the soil,
as well as in avian excreta and is mainly responsible for infection in
patients with defective cellular immunity.1 C. gattii was previously
believed to be geographically restricted to tropical and subtropical
climates.2 However, in the past decade C. gattii has been reported
worldwide and has a specialized ecological niche on trees and the
hollow of trees.2 It has been implicated as the cause of infection in
immune-competent patients.1,2
Cryptococcal infection occurs by inhalation of infected spores or
desiccated yeast cells.1 Infection is usually asymptomatic and may
even occur in childhood.1 During periods of severe cell-mediated
immunodeﬁciency, the organism may enter the circulation,
leading to disseminated disease.1 Clinical manifestations most
commonly involve the lung and CNS, although other sites namely
the skin, bone marrow, and genitourinary tract may be involved.1Skeletal cryptococcal infections are uncommon, occurring in
5–10% of patients with disseminated disease.3 Isolated skeletal
infections are even less common.3 Only 47 cases of isolated
cryptococcal osteomyelitis in HIV-uninfected patients have
been reported between 1974 and 2005.4 The most common
predisposing factors were sarcoidosis, tuberculosis, steroid
therapy, lymphoma, leukemia, Hodgkin’s disease, and diabetes
mellitus.4
Skeletal cryptococcal infections may arise due to hematogenous
spread from a primary pulmonary source, however direct
inoculation through the skin and contiguous spread is also
possible.4 The infection may occur at a single or at multiple sites,
with the vertebrae, ribs, tibia, and femur being the most commonly
affected.3–5 The diagnosis is often difﬁcult, as presentation is non-
speciﬁc; namely soft tissue swelling, bony tenderness, and
occasionally fever.3 The duration of symptoms may persist for
up to 33 months prior to diagnosis.3
The radiological ﬁndings are non-speciﬁc, and lesions
typically appear purely lytic, with discrete margins and with
or without periosteal reactions.3–5 The differential diagnosis for
the radiological features include neoplastic lesions as well as
other infections, namely Staphylococcus aureus, Brucella spp,
Actinomyces spp, and Mycobacteria spp.3 Ultimately, however, the
diagnosis of cryptococcosis is made by identiﬁcation of the
organism in the bony lesion.3–5 This may be from draining
sinuses, aspiration, incision and drainage, or open biopsy.3 Once
Cryptococcus is identiﬁed, disseminated disease should be
excluded.3 Investigations include a chest radiograph, serum
examination for antibodies, lumbar puncture for India ink
staining, antigen testing and culture, and skin lesion biopsy for
microscopy and culture.3
Due to the rarity of cryptococcal osteomyelitis there are no
speciﬁc recommendations regarding the optimal treatment.
Surgical debridement reduces infective burden and provides an
opportunity to obtain specimens for histological and microbiolog-
ical examination, and subsequent medical management with
antifungal therapy is recommended.3–5The Infectious Diseases
Society of America does offer treatment recommendations for non-
meningeal, non-pulmonary cryptococcosis in HIV-seronegative
patients. In cases where cryptococcemia or disseminated disease is
present, treatment with amphotericin B at 0.7–1 mg/kg/day and
ﬂucytosine for 2 weeks is suggested.6 This is followed by
ﬂuconazole at 12 mg/kg/day or 800 mg daily for 8 weeks.6
Thereafter, the dose of ﬂuconazole should be decreased to 3 mg/
kg/day or 200 mg daily and continued for 6–12 months.6 The
response to therapy should be monitored radiologically and
followed up, as the infection may relapse and cause chronic
infections.3
Unfortunately, ﬂucytosine is not available in the public sector in
South Africa and only ﬂuconazole 400 mg daily and amphotericin B
were available. Furthermore, we were unable to make a distinction
between C. gattii and C. neoformans in this patient.
In conclusion, isolated osteomyelitis is a rare manifestation of
cryptococcosis, but should be considered as a differential for lytic
osseous lesions, even in the absence of HIV infection. Early
intervention ensures prompt diagnosis and treatment and may
prevent morbidity and mortality.
Conﬂict of interest: Halima Dawood has received honoraria from
MSD-South Africa and Novartis-South Africa for speaking
engagements and has received a travel grant from Novartis-
South Africa.
References
1. Warkentien T, Crum-Cianﬂone NF. An update on Cryptococcus among HIV
infected persons. Int J STD AIDS 2010;21:679–84.
Y. Ramkillawan et al. / International Journal of Infectious Diseases 17 (2013) e1229–e1231 e12312. Springer DJ, Chaturvedi V. Projecting global occurrence of Cryptococcus gattii.
Emerg Infect Dis 2010;16:14–9.
3. Wood L, Miedzinski L. Skeletal Cryptococcus: case report and review of litera-
ture. Can J Infect Dis 1996;7:125–33.
4. Qadir I, Ali F, Zafar U, Umar M. Isolated cryptococcal osteomyelitis in an
immunocompetent patient. J Infect Dev Ctries 2011;5:669–73.5. Goldshteyn N, Zanchi A, Cooke K, Agha R. Cryptococcal osteomyelitis of the humeral
head initially diagnosed as avascular necrosis. South Med J 2006;99: 1140–1.
6. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al.
Clinical practice guidelines for the management of cryptococcal disease: 2010
update by the Infectious Diseases Society of America. Clin Infect Dis 2010;
50:291–322.
